Preparing for total pancreatectomy – what the evidence actually says
Total pancreatectomy is the rarest of the three main pancreatic operations and the one with the most consequential long-term implications. If you or a family member has been told this is the recommended treatment, you will already understand it is a significant undertaking. This page sets out what the published evidence actually shows about preparing for the operation, what to expect on the day, what recovery looks like in the first weeks, and – most importantly – what life looks like afterwards. It is written for patients in the United States, Canada, Ireland, the United Kingdom, and other English-speaking countries by a consultant hepatopancreatobiliary (HPB) surgeon.
Where claims are made, they are referenced to clinical practice guidelines from the National Institute for Health and Care Excellence (NICE), the International Study Group on Pancreatic Surgery (ISGPS), the Enhanced Recovery After Surgery (ERAS) Society, the International Cancer of the Pancreas Screening (CAPS) consortium for hereditary cases, and the European Association for Endoscopic Surgery (EAES). Full source list at the end.
New to prehab? Start with our complete guide to what prehab is.
What the operation is, and why it is offered
Total pancreatectomy is the surgical removal of the entire pancreas, together with the duodenum (the first part of the small intestine, anatomically inseparable from the pancreatic head), the gallbladder, the distal common bile duct, and – in the great majority of cases – the spleen. The remaining stomach, small intestine, and bile duct are then reconstructed to restore continuity of the digestive tract. The operation combines, in effect, what a Whipple operation (head of pancreas plus duodenum) and a distal pancreatectomy and splenectomy (body, tail, and spleen) would each do separately.
Because the operation has very specific lifelong consequences – complete absence of pancreatic insulin production and complete absence of pancreatic digestive enzymes – it is not chosen lightly. It is offered when the disease cannot be adequately treated with a partial resection. The principal indications are:
• Multifocal intraductal papillary mucinous neoplasm (IPMN) involving the entire pancreas, particularly when there is high-grade dysplasia or invasive carcinoma present in any portion.
• Familial or hereditary pancreatic cancer in a patient with multiple cancer foci or with extensive precancerous changes throughout the gland – for example carriers of pathogenic BRCA2, PALB2, ATM, CDKN2A, STK11, PRSS1, or Lynch-syndrome mutations identified through CAPS-consortium screening protocols.
• Some cases of pancreatic adenocarcinoma where the tumour involves or threatens both the head and body or tail simultaneously and a single-region resection cannot achieve clear margins.
• Some neuroendocrine tumours with extensive multifocal pancreatic involvement.
• Severe chronic pancreatitis with intractable pain that has not responded to other surgical or endoscopic options – in this setting, total pancreatectomy is sometimes combined with islet auto-transplantation (TP-IAT) in specialist centres, where the patient’s own insulin-producing islets are extracted from the removed pancreas and re-implanted in the liver to preserve some endogenous insulin production.
The operation can be performed open, laparoscopically, or robotically. The minimally invasive approaches are increasingly used in selected cases at experienced centres, but most total pancreatectomies worldwide remain open operations because of the complexity and the patient populations involved.
Before your operation – what actually helps
Preparation for total pancreatectomy follows the principles of major abdominal surgery preparation, with three additional considerations that are essential rather than optional.
1. Pre-operative endocrinology referral and diabetes education.
Every patient undergoing total pancreatectomy will develop diabetes – there is no remaining pancreatic tissue, so there is no remaining insulin production. This is a specific form of diabetes (sometimes called pancreatogenic diabetes or Type 3c diabetes) which differs from Type 1 and Type 2 diabetes in important ways. The most clinically significant difference is that the alpha cells of the pancreas, which normally produce glucagon to counter low blood sugar, are also removed – meaning your body cannot mount its usual hormonal response to hypoglycaemia. This makes blood-sugar control more challenging and the consequences of low blood sugar potentially more serious.
An endocrinology referral before surgery – ideally several weeks before – gives you time to meet the team who will manage your insulin regimen, to learn the principles of insulin dosing, carbohydrate counting, hypoglycaemia recognition, and the use of continuous glucose monitoring (CGM). Many centres now consider CGM (and in some cases, an insulin pump) as the standard of care for total-pancreatectomy patients rather than multiple daily injections, because the tighter feedback loop helps mitigate the brittleness of pancreatogenic diabetes. Front-loading this education before surgery – rather than trying to absorb it in the chaotic post-operative week – is the single most useful preparation you can make.
2. Pre-operative pancreatic enzyme replacement (PERT) counselling.
After total pancreatectomy you will have complete pancreatic exocrine insufficiency – your body produces no pancreatic digestive enzymes at all. You will need pancreatic enzyme replacement therapy (PERT – most commonly Creon or equivalent) with every meal and every snack for the rest of your life. Typical doses are higher than after a Whipple or distal pancreatectomy (often 50,000–75,000 units of lipase or more per main meal, lower for snacks) and need to be titrated to fat content and symptoms. Meeting your gastroenterologist or specialist nurse before surgery to understand how PERT is dosed and adjusted – and how to carry it with you for unexpected meals or travel – makes the post-operative learning curve much less steep. In Ireland, PERT is covered under the Long Term Illness scheme for patients with pancreatic conditions; in the UK it is on NHS prescription.
3. Vaccination if splenectomy is included (it usually is).
The vaccination programme is identical to that required before a distal pancreatectomy with splenectomy:
• Pneumococcal vaccine (Pneumovax 23 and Prevenar 13/15/20 – your team will advise on the current schedule)
• Meningococcal vaccine (covering serogroups A, C, W, Y, plus serogroup B – typically two separate vaccines)
• Haemophilus influenzae type b (Hib) vaccine
Ideally these are given at least two weeks before surgery to allow your immune system to mount a full response. After surgery you will be advised to take daily low-dose antibiotic prophylaxis (typically penicillin V, or alternative if penicillin-allergic) for at least two years and often indefinitely, alongside booster vaccinations on a defined schedule. Your surgical team will provide written instructions and a splenectomy alert card.
4. General prehabilitation.
Beyond the three specific considerations above, the principles of major-surgery prehabilitation apply: optimise nutrition (adequate protein intake, 1.2-1.5 g per kg body weight per day or 0.55 to 0.7 grams per pound), maintain or improve physical activity (walking 30-45 minutes daily plus light resistance two to three times per week), stop smoking at least four weeks before surgery, and substantially reduce alcohol intake. The ERAS Society guidelines for pancreatic surgery support each of these as evidence-based preparatory measures.
5. Psychological preparation.
This is rarely addressed openly in patient information but it matters. Total pancreatectomy involves committing to a lifelong regimen of insulin, PERT with every meal, and the vigilance required to live well with brittle diabetes. The published evidence is clear that patients who go into the operation with realistic expectations of the long-term commitment cope better than those who do not. Most major HPB units will arrange a meeting with a clinical nurse specialist or psychology service before surgery; if this is not offered, ask for it.
The day of your operation
Total pancreatectomy is performed under general anaesthetic. Operating time typically ranges from four to seven hours depending on disease complexity, prior surgery, and surgical approach. You will have either a single longer upper-abdominal incision (open) or four to six smaller incisions (laparoscopic or robotic).
One important point that may surprise patients: because there is no pancreatic anastomosis (no remaining pancreas to sew to anything), the operation does not carry the risk of post-operative pancreatic fistula (POPF) that complicates Whipple operations and distal pancreatectomies. The pancreatic-stump leak risk that is the headline complication of partial pancreatic resections does not exist after total pancreatectomy. This is one of the few ways in which total pancreatectomy is technically simpler than its partial equivalents.
You will wake up in the recovery area, then transfer to a high-dependency unit or surgical ward depending on local practice. Pain is managed with intravenous and oral analgesia. Insulin is started intravenously in the immediate post-operative period and transitioned to subcutaneous insulin as you begin to eat and drink. ERAS protocols apply – early sips of fluid within hours, early mobilisation within the first 24 hours, and rapid removal of unnecessary tubes and drips.
Recovery – what to expect, week by week
Recovery from total pancreatectomy is broadly similar to Whipple recovery, with the key difference being the immediate establishment of insulin and PERT regimens.
• First 48 hours: intravenous insulin infusion titrated to frequent blood-glucose checks. Pain controlled with regional anaesthesia (epidural or transversus abdominis plane block) plus oral or intravenous analgesia. Walking with a nurse or physiotherapist on day one or day two. Sips of fluid then graduated to oral diet.
• First week: transition from intravenous to subcutaneous insulin, with the endocrinology team or specialist diabetes nurse working alongside the surgical team. Start of oral PERT with each meal and snack from the first day of solid diet. Hospital stay typically 7-14 days, longer if there are complications or if diabetes management is taking time to stabilise.
• Two to four weeks: discharge home with a clear written plan covering insulin doses (with specific instructions for sick-day rules, hypoglycaemia management, and what to do if eating is reduced), PERT doses, splenectomy precautions, and follow-up appointments. Most patients are walking comfortably at home but not yet driving.
• Six to twelve weeks: gradual return to most normal activities. Many patients return to sedentary work at six to eight weeks. Heavy lifting and vigorous exercise typically deferred until eight to twelve weeks. Continued close diabetes follow-up – the first three months are when most patients’ insulin regimens are refined and optimised.
Persistent severe pain, persistent fever, repeated hypoglycaemia, persistent vomiting, or wound problems are not part of normal recovery – contact your surgical team or attend an emergency department. Recurrent unexplained hypoglycaemia in particular needs urgent review, because the absence of glucagon response means it can escalate quickly.
Diet, digestion, and the daily reality of PERT
After total pancreatectomy you will need PERT with every meal and every snack for life. This is not a temporary measure during recovery – it is permanent, because your body produces no pancreatic enzymes at all. The good news is that PERT is well-tolerated, generally safe, and with appropriate dosing allows you to eat a normal varied diet including fat.
Practical points worth understanding before surgery:
• Take PERT capsules with the first bite of each meal or snack; if the meal lasts more than 30 minutes, take a second dose mid-meal. The enzymes only work for a limited time after release.
• Dose to the fat content of the meal. A small low-fat snack might require 25,000 units of lipase; a large fatty meal might require 75,000 units or more. Your specialist team will help you calibrate.
• Symptoms of inadequate PERT include greasy or floating stools, urgent loose stools, abdominal bloating after meals, and weight loss. If these occur, the dose is too low.
• PERT capsules should not be chewed or crushed (the coating is designed to release enzymes in the small bowel, not the stomach). If swallowing is difficult, the capsules can be opened and the granules taken with a small amount of acidic food such as apple sauce — never with hot food or alkaline foods, which damage the granules.
• Carry PERT with you at all times. Travel — even short trips — requires a supply in your hand luggage.
Most patients eat a fully normal varied diet within weeks of surgery, including fatty foods, provided PERT is taken correctly. There are no permanent food restrictions imposed by the operation itself.
Living with pancreatogenic (Type 3c) diabetes
This is the part of life after total pancreatectomy that requires the most ongoing attention. Pancreatogenic diabetes differs from Type 1 and Type 2 diabetes in three clinically important ways:
• There is no endogenous insulin production at all – every unit of insulin in your body comes from injection or infusion.
• There is no glucagon response to hypoglycaemia – your body cannot mount its usual hormonal counter-regulation when blood sugar drops. This makes hypoglycaemia more dangerous and more prolonged than in Type 1 diabetes.
• Insulin sensitivity is often higher than in Type 2 diabetes (because the underlying problem is insulin deficiency rather than insulin resistance), which can make doses more difficult to predict.
Practical implications, in the order most patients learn them:
• Continuous glucose monitoring (CGM) is increasingly considered standard of care. The real-time feedback transforms the management of brittle pancreatogenic diabetes compared with finger-prick testing alone.
• Hypoglycaemia awareness training matters – recognise the early symptoms, treat early, and always carry fast-acting carbohydrate.
• Sick-day rules are essential. Insulin requirements change dramatically with illness, vomiting, or reduced food intake. Your diabetes team will give written sick-day guidance — keep it accessible.
• Driving – declare your diabetes to the relevant licensing authority (Road Safety Authority in Ireland; DVLA in the UK). Specific rules apply to insulin-treated diabetics regarding blood-glucose checks before and during driving.
• Travel – carry a doctor’s letter explaining your need for insulin, glucose monitoring equipment, and PERT, particularly for international travel. Time-zone changes require pre-planned insulin adjustments – discuss with your team before any long-haul trip.
• Pregnancy – possible but requires very close pre-conception planning and specialist multidisciplinary care.
The published outcomes data suggest that, with modern insulin regimens and CGM technology, long-term diabetes-related complication rates after total pancreatectomy are now closer to those of well-managed Type 1 diabetes than the much-cited historical figures from before CGM and insulin-pump availability.
Splenectomy precautions
If your operation included splenectomy (it almost always does), the lifelong precautions are the same as for any patient without a spleen:
• Continue daily prophylactic antibiotics (typically penicillin V 250 mg twice daily, or an alternative if penicillin-allergic). Most current Irish and UK guidance suggests at least two years and often indefinitely.
• Keep vaccinations current – pneumococcal booster every five years, annual influenza vaccine, meningococcal boosters per your team’s schedule.
• Carry a splenectomy alert card; consider medical alert jewellery especially when travelling.
• Seek urgent medical attention for any unexplained fever or rapidly progressive illness, particularly abroad or in malaria-endemic regions.
• Mention your splenectomy to every treating doctor, including dentists before any procedure.
Bottom line
Total pancreatectomy is a significant operation with significant lifelong consequences – but the published outcomes data from modern HPB units, combined with current insulin technology, PERT regimens, and splenectomy management, show that patients can and do live full and active lives afterwards. The most consequential preparation is not physical; it is education – meeting your endocrinology and gastroenterology teams before surgery, learning the principles of insulin dosing and PERT before you need them in earnest, and going into the operation with realistic expectations of the long-term commitment. Trust your surgical and medical teams’ specific advice for your case; ignore the louder corners of the internet.
After your surgery:
[Living with type 3c diabetes — the practical guide]
PERT – getting pancreatic enzyme replacement right (a practical guide)
Vaccines and antibiotics if your spleen was also removed
Sources
Key references underpinning the clinical statements in this article:
• National Institute for Health and Care Excellence (NICE). Pancreatic cancer in adults: diagnosis and management. NICE guideline NG85.
• Enhanced Recovery After Surgery (ERAS) Society. Guidelines for perioperative care for pancreaticoduodenectomy. Lassen K et al., World Journal of Surgery (relevant principles for total pancreatectomy peri-operative care).
• International Cancer of the Pancreas Screening (CAPS) Consortium guidelines on management of patients at high risk for hereditary pancreatic cancer. Goggins M et al., Gut.
• Petersen GM et al. Familial pancreatic cancer — review and management recommendations. Familial Cancer.
• Total pancreatectomy with islet auto-transplantation (TP-IAT) — published outcomes from the Minnesota and Cincinnati series. Bellin MD et al., Annals of Surgery.
• Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology — for Type 3c diabetes pathophysiology and management principles.
• British Society for Haematology guideline: prevention and treatment of infection in patients with an absent or dysfunctional spleen.
Reviewed by Mr Tom Gallagher, Consultant HPB Surgeon, St Vincent’s Healthcare Group, Dublin. Last updated May 23rd, 2026.